Related Experiment Video
Updated: Apr 26, 2026
04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
1.4K
The relationship between uric acid and erectile dysfunction in hypertensive subjects
Alpay Aribas1, Mehmet Kayrak, Seref Ulucan
1Department of Cardiology, Necmettin Erbakan University Meram School of Medicine , Meram, Konya , Turkey.
Blood Pressure
|July 17, 2014
Summary
High uric acid (UA) levels are linked to erectile dysfunction (ED) in hypertensive patients. Monitoring UA may help identify men with ED, regardless of blood pressure control.
Area of Science:
- Cardiovascular Medicine
- Urology
- Endocrinology
Background:
- Endothelial dysfunction is a primary contributor to erectile dysfunction (ED).
- Uric acid (UA) serves as a biomarker for endothelial dysfunction.
- This study investigates the association between elevated UA and ED in hypertensive individuals.
Purpose of the Study:
- To determine the relationship between uric acid levels and erectile dysfunction in hypertensive patients.
- To identify independent predictors of erectile dysfunction in this population.
Main Methods:
- Two hundred hypertensive patients with normal treadmill exercise tests were recruited.
- Participants were categorized into two groups based on the Sexual Health Inventory for Men (SHIM) scores: ED (SHIM < 21) and normal erectile function (SHIM ≥ 21).
- Comparative analysis and regression modeling were used to analyze determinants of ED.
Main Results:
- The prevalence of ED among the hypertensive patients was 55.0%.
- Significantly higher uric acid levels were observed in the ED group (6.20 ± 1.56) compared to the normal function group (5.44 ± 1.32, p = 0.01).
- Age, smoking, and uric acid levels were identified as independent determinants of ED.
Conclusions:
- Uric acid is an independent predictor of erectile dysfunction in hypertensive patients, independent of blood pressure control.
- Screening for erectile dysfunction is recommended for hypertensive patients with elevated uric acid levels.
Related Concept Videos
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
815
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
815
01:20Disorders of the Male Reproductive System
5.2K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
379
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
379
01:23Antihypertensive Drugs: Vasodilators
2.5K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.5K
01:16Antihypertensive Drugs: Action of Diuretics
2.7K
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
2.7K
01:29Hypertension II: Pathophysiology
1.7K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.7K